LoHist D

Manufacturer
Larken Laboratories, Inc.
Effective date
2026-11-03
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-11-06 02:04:20

Label at a glance#

ProductLoHist-D
Active ingredientCHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE
Label structure16 sections

Indications and uses

temporarily relieves these symptoms due to hay fever (allergic rhinitis): runny nose sneezing itching of the nose or throat itchy, watery eyes temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies. temporarily restores freer breathing through the nose

Dosage and administration

Do not exceed 4 doses in a 24-hour period Age Dose Adults and children over 12 years of age 2 teaspoonfuls (10 mL) every 4 to 6 hours Children 6 to under 12 years of age 1 teaspoonful (5 mL) every 4 to 6 hours Children under 6 years of age Ask your doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

(In each 5 mL teaspoonful)

Chlorpheniramine Maleate, USP 2 mg

Pseudoephedrine HCl, USP 30 mg

Purpose

OTC - PURPOSE SECTION

Chlorpheniramine Maleate Antihistamine

Pseudoephedrine HCl Nasal decongestant

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever (allergic rhinitis):

  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, watery eyes
  • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies.
  • temporarily restores freer breathing through the nose

Warnings

WARNINGS SECTION

Do not use

  • to sedate a child or make a child sleepy
  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this drug.

Ask a Doctor before use if you have

OTC - ASK DOCTOR SECTION

  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • glaucoma
  • trouble urinating due to an enlarged prostate gland
  • a breathing problem such as emphysema or chronic bronchitis

Ask a doctor or pharmacist before use if you are.

OTC - ASK DOCTOR/PHARMACIST SECTION

  • taking any other nasal decongestant or stimulant
  • taking sedatives or tranquilizers

When using this product

OTC - WHEN USING SECTION

Do not exceed recommended dosage.

  • marked drowsiness may occur
  • avoid alcoholic beverages
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery
  • excitability may occur, especially in children

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • nervousness, dizziness, or sleeplessness occur.
  • symptoms do not improve within 7 days or are accompanied by fever.

If pregnant or breast feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of the reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Do not exceed 4 doses in a 24-hour period

AgeDose
Adults and children over 12 years of age2 teaspoonfuls (10 mL) every 4 to 6 hours
Children 6 to under 12 years of age1 teaspoonful (5 mL) every 4 to 6 hours
Children under 6 years of ageAsk your doctor

Other information

SPL UNCLASSIFIED SECTION

  • store at 20°-25°C (68°-77°F)
  • very low sodium, contains less than 1 mg sodium per 5 mL teaspoonful

Inactive ingredients

INACTIVE INGREDIENT SECTION

grape flavoring, methylparaben, polyethylene glycol, propylparaben, purified water saccharin sodium, and sorbitol

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-601-855-7678 weekdays from 9:00 am to 4:00 pm CST or go to www.larkenlabs.com.

Package Label, Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Figure 1:16 oz. bottle label

figure-01
figure-01

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130368047159168GTIN-13: 0368047159168
EAN-13: 0368047159168
GTIN-12: 368047159168
UPC-A: 368047159168
GTIN storage (14 digits): 00368047159168
figure-01.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68047-15968047-159-16

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-07-28daily-update2026-08-01 05:10:17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LoHist-DCHLORPHENIRAMINE MALEATE / PSEUDOEPHEDRINE HCLLarken Laboratories, Inc.efaa354e-c25c-405b-9d30-001c2796978c2026-11-03WarningsExact identifier
ndc (package): 68047-159-16
ndc (product): 68047-159
ndc11 (package): 68047015916
spl id: 5f6362dc-25c7-d157-e063-6394a90a11b1
spl set id: efaa354e-c25c-405b-9d30-001c2796978c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.